Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why

Advanced Lipoxidation End-products (ALEs) are modified proteins that can act as pathogenic factors in several chronic diseases. Several molecular mechanisms have so far been considered to explain the damaging action of ALEs and among these a pathway involving the receptor for advanced glycation end...

Full description

Bibliographic Details
Main Authors: Marco Mol, Genny Degani, Crescenzo Coppa, Giovanna Baron, Laura Popolo, Marina Carini, Giancarlo Aldini, Giulio Vistoli, Alessandra Altomare
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:Redox Biology
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231718310218
id doaj-546fef2e2a5446dabd86d7b619b86228
record_format Article
spelling doaj-546fef2e2a5446dabd86d7b619b862282020-11-24T21:45:44ZengElsevierRedox Biology2213-23172019-05-0123Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons whyMarco Mol0Genny Degani1Crescenzo Coppa2Giovanna Baron3Laura Popolo4Marina Carini5Giancarlo Aldini6Giulio Vistoli7Alessandra Altomare8Department of Pharmaceutical Sciences, Via Mangiagalli 25, Università degli Studi di Milano, 20133 Milano, ItalyDepartment of Biosciences, Via Celoria 26, Università degli Studi di Milano, 20133 Milano, ItalyDepartment of Pharmaceutical Sciences, Via Mangiagalli 25, Università degli Studi di Milano, 20133 Milano, ItalyDepartment of Pharmaceutical Sciences, Via Mangiagalli 25, Università degli Studi di Milano, 20133 Milano, ItalyDepartment of Biosciences, Via Celoria 26, Università degli Studi di Milano, 20133 Milano, ItalyDepartment of Pharmaceutical Sciences, Via Mangiagalli 25, Università degli Studi di Milano, 20133 Milano, ItalyDepartment of Pharmaceutical Sciences, Via Mangiagalli 25, Università degli Studi di Milano, 20133 Milano, Italy; Corresponding author.Department of Pharmaceutical Sciences, Via Mangiagalli 25, Università degli Studi di Milano, 20133 Milano, ItalyDepartment of Pharmaceutical Sciences, Via Mangiagalli 25, Università degli Studi di Milano, 20133 Milano, ItalyAdvanced Lipoxidation End-products (ALEs) are modified proteins that can act as pathogenic factors in several chronic diseases. Several molecular mechanisms have so far been considered to explain the damaging action of ALEs and among these a pathway involving the receptor for advanced glycation end products (RAGE) should be considered. The aim of the present work is to understand if ALEs formed from lipid peroxidation derived reactive carbonyl species (RCS) are able to act as RAGE binders and also to gain a deeper insight into the molecular mechanisms involved in the protein-protein engagement. ALEs were produced in vitro, by incubating human serum albumin (HSA) with 4-hydroxy-trans− 2-nonenal (HNE), acrolein (ACR) and malondialdehyde (MDA). The identification of ALEs was performed by MS. ALEs were then subjected to the VC1 Pull-Down assay (VC1 is the ligand binding domain of RAGE) and the enrichment factor (the difference between the relative abundance in the enriched sample minus the amount in the untreated one) as an index of affinity, was determined. Computation studies were then carried out to explain the factors governing the affinity of the adducted moieties and the site of interaction on adducted HSA for VC1-binding. The in silico analyses revealed the key role played by those adducts which strongly reduce the basicity of the modified residues and thus occur at their neutral state at physiological conditions (e.g. the MDA adducts, dihydropyridine-Lysine (DHPK) and N-2-pyrimidyl-ornithine (NPO), and acrolein derivatives, N-(3-formyl-3,4-dehydro-piperidinyl) lysine, FDPK). These neutral adducts become unable to stabilize ion-pairs with the surrounding negative residues which thus can contact the RAGE positive residues.In conclusion, ALEs derived from lipid peroxidation-RCS are binders of RAGE and this affinity depends on the effect of the adduct moiety to reduce the basicity of the target amino acid and on the acid moieties surrounding the aminoacidic target. Keywords: Advanced lipoxidation end products (ALEs), Human serum albumin (HSA), RAGE, Pull-down assay, VC1 domain, Reactive Carbonyl Species (RCS), 4-hydroxy-trans− 2-nonenal (HNE), Acrolein (ACR) and malondialdehyde (MDA)http://www.sciencedirect.com/science/article/pii/S2213231718310218
collection DOAJ
language English
format Article
sources DOAJ
author Marco Mol
Genny Degani
Crescenzo Coppa
Giovanna Baron
Laura Popolo
Marina Carini
Giancarlo Aldini
Giulio Vistoli
Alessandra Altomare
spellingShingle Marco Mol
Genny Degani
Crescenzo Coppa
Giovanna Baron
Laura Popolo
Marina Carini
Giancarlo Aldini
Giulio Vistoli
Alessandra Altomare
Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
Redox Biology
author_facet Marco Mol
Genny Degani
Crescenzo Coppa
Giovanna Baron
Laura Popolo
Marina Carini
Giancarlo Aldini
Giulio Vistoli
Alessandra Altomare
author_sort Marco Mol
title Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
title_short Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
title_full Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
title_fullStr Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
title_full_unstemmed Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
title_sort advanced lipoxidation end products (ales) as rage binders: mass spectrometric and computational studies to explain the reasons why
publisher Elsevier
series Redox Biology
issn 2213-2317
publishDate 2019-05-01
description Advanced Lipoxidation End-products (ALEs) are modified proteins that can act as pathogenic factors in several chronic diseases. Several molecular mechanisms have so far been considered to explain the damaging action of ALEs and among these a pathway involving the receptor for advanced glycation end products (RAGE) should be considered. The aim of the present work is to understand if ALEs formed from lipid peroxidation derived reactive carbonyl species (RCS) are able to act as RAGE binders and also to gain a deeper insight into the molecular mechanisms involved in the protein-protein engagement. ALEs were produced in vitro, by incubating human serum albumin (HSA) with 4-hydroxy-trans− 2-nonenal (HNE), acrolein (ACR) and malondialdehyde (MDA). The identification of ALEs was performed by MS. ALEs were then subjected to the VC1 Pull-Down assay (VC1 is the ligand binding domain of RAGE) and the enrichment factor (the difference between the relative abundance in the enriched sample minus the amount in the untreated one) as an index of affinity, was determined. Computation studies were then carried out to explain the factors governing the affinity of the adducted moieties and the site of interaction on adducted HSA for VC1-binding. The in silico analyses revealed the key role played by those adducts which strongly reduce the basicity of the modified residues and thus occur at their neutral state at physiological conditions (e.g. the MDA adducts, dihydropyridine-Lysine (DHPK) and N-2-pyrimidyl-ornithine (NPO), and acrolein derivatives, N-(3-formyl-3,4-dehydro-piperidinyl) lysine, FDPK). These neutral adducts become unable to stabilize ion-pairs with the surrounding negative residues which thus can contact the RAGE positive residues.In conclusion, ALEs derived from lipid peroxidation-RCS are binders of RAGE and this affinity depends on the effect of the adduct moiety to reduce the basicity of the target amino acid and on the acid moieties surrounding the aminoacidic target. Keywords: Advanced lipoxidation end products (ALEs), Human serum albumin (HSA), RAGE, Pull-down assay, VC1 domain, Reactive Carbonyl Species (RCS), 4-hydroxy-trans− 2-nonenal (HNE), Acrolein (ACR) and malondialdehyde (MDA)
url http://www.sciencedirect.com/science/article/pii/S2213231718310218
work_keys_str_mv AT marcomol advancedlipoxidationendproductsalesasragebindersmassspectrometricandcomputationalstudiestoexplainthereasonswhy
AT gennydegani advancedlipoxidationendproductsalesasragebindersmassspectrometricandcomputationalstudiestoexplainthereasonswhy
AT crescenzocoppa advancedlipoxidationendproductsalesasragebindersmassspectrometricandcomputationalstudiestoexplainthereasonswhy
AT giovannabaron advancedlipoxidationendproductsalesasragebindersmassspectrometricandcomputationalstudiestoexplainthereasonswhy
AT laurapopolo advancedlipoxidationendproductsalesasragebindersmassspectrometricandcomputationalstudiestoexplainthereasonswhy
AT marinacarini advancedlipoxidationendproductsalesasragebindersmassspectrometricandcomputationalstudiestoexplainthereasonswhy
AT giancarloaldini advancedlipoxidationendproductsalesasragebindersmassspectrometricandcomputationalstudiestoexplainthereasonswhy
AT giuliovistoli advancedlipoxidationendproductsalesasragebindersmassspectrometricandcomputationalstudiestoexplainthereasonswhy
AT alessandraaltomare advancedlipoxidationendproductsalesasragebindersmassspectrometricandcomputationalstudiestoexplainthereasonswhy
_version_ 1725904621618069504